IPO Insider



Highlighted IPO


On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.

J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.

Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.


Recently Priced IPOs

Date Company Ticker Shares IPO Price Current % Underwriters
6/30/2016 HarborOne Bank HONE 14.454 Mil $10.00 $12.81 28.10%
6/30/2016 Syros Pharmaceuticals SYRS 4 Mil $12.50 $19.35 54.80% Cowen and Company and Piper Jaffray & Co
6/23/2016 Twilio, Inc. TWLO 10 Mil $15.00 $34.03 126.87% Goldman, Sachs & Co., J.P. Morgan, Allen & Company LLC, Pacific Crest Securities, JMP Securities, William Blair, Canaccord Genuity
6/22/2016 Selecta Biosciences SELB 5 Mil $14.00 $14.02 0.14% UBS Investment Bank and Stifel
6/10/2016 Atkore International ATKR 12 Mil $16.00 $16.85 5.31% Credit Suisse, Deutsche BankSecurities and J.P. Morgan
6/10/2016 China Online Education Group COE 2.4 Mil $19.00 $20.34 7.05% Morgan Stanley, Credit Suisse
6/2/2016 Clearside Biomedical CLSD 7.2 Mil $7.00 $6.78 -3.14% Cowen and Company and Stifel
6/2/2016 Moleculin Biotech MBRX 1.54 Mil $6.00 $7.04 17.33% Bonwick Capital Partners, LLC
6/2/2016 NantHealth NH 6.5 Mil $14.00 $12.87 -8.07% Jefferies LLC and Cowen and Company
5/26/2016 GMS Inc. GMS 7 Mil $21.00 $21.92 4.38% Barclays Capital Inc. and Credit Suisse Securities

Upcoming IPOs

Date Company Ticker Shares Expected Price Underwriters
N/AUTAC Holdings Ltd.UTACN/AN/ABofA Merrill Lynch, Citigroup, Credit Suisse
N/ASidoti & Company, Inc.SDTIN/AN/AWR Hambrecht + Co., Sidoti & Company
N/APoseidon Containers Holdings Corp.PCONN/A$14-$16Morgan Stanley, UBS Investment Bank
N/ANEP GroupNEPG13 Mil$15-$17Barclays, Morgan Stanley, Jefferies, Macquarie Capital, RBC Capital Markets
N/ABioCardia, Inc.BCDA3.9 Mil$12-$14Cantor Fitzgerald & Co., Roth Capital Partners, Maxim Group LLC
N/AGenSight Biologics S.A.GBITN/AN/AMorgan Stanley, Goldman, Sachs & Co., Cowen and Company, Wedbush PacGrow
N/ADigicel Group LimitedDCEL124.1 Mil$13-$16J.P. Morgan, UBS Investment Bank, Citigroup, Barclays, Credit Suisse
N/AVIZIO, Inc.VZION/AN/ABofA Merrill Lynch, Deutsche Bank Securities, Citigroup, BMO Capital Markets, Piper Jaffray, Wells Fargo Securities, Roth Capital Partners
N/AGenSight Biologics S.A.GNST4.7 Mil$13-$15Leerink Partners, Evercore ISI, Canaccord Genuity
N/ABoxlightBOXL1.818 Mil$10-$12Aegis Capital Corp

Upcoming IPO

Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.

The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.

Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.